Mode VC
New York

Global BioAccess Fund

Global BioAccess Fund, based in New York, backs life sciences and healthtech startups at Series A and B, can lead rounds, and has invested in Odyssey Therapeutics and Epsilogen.

Website
Entry stageSeries A, Series B
Check sizen/a
Leads roundsYes
FocusLife sciences, Healthtech
Latest fundn/a
Investing team6 peopleNo activity since Sep

Who you would pitch at Global BioAccess Fund

6 people on the investing team, 3 of them partners who can make the call. Partners are listed first.

Bruce Roberts
Bruce RobertsManaging PartnerHe leads the fund alongside other managing directors to invest in life sciences ventures.
Lisa Wisniewski
Lisa WisniewskiManaging DirectorShe is a Managing Director at RM Global BioAccess Fund.
Ted Moon
Ted MoonManaging PartnerHe is one of the managing directors leading the fund.
Sonia Gulati
Sonia GulatiPrincipalShe has a background in life sciences venture capital and biotechnology strategy consulting.
Dave Praharaj
Dave PraharajSenior AssociateHe holds an MD and is part of the team at the fund.
Kevin Cyr
Kevin CyrResearch AssociateHe is also a Stanford Biodesign Fellow and has an MD.

Work here and something is wrong? Ask for a correction.

Check size not reported yet.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

Before you pitch

How to reach them[email protected]

Notable investments

Odyssey TherapeuticsEpsilogenVittoria BiotherapeuticsCartography BiosciencesAcesion PharmaShiratronicsEnsho TherapeuticsNuvig TherapeuticsAlveus Therapeutics
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when Global BioAccess Fund is active

One email when this firm shows new activity. Nothing else.

Firms like Global BioAccess Fund

Acorn Bioventures$100K to $10M
Catalio Capital ManagementCheck size not reported
Easton Capital$1M to $10M
New Leaf Venture Partners$1M to $30M
OrbiMed$1M to $30M+
Signet Healthcare Partners$10M to $30M+

On these lists

Series A healthtech investors in New York39Series A life sciences investors in New York26Series B healthtech investors in New York22Series B life sciences investors in New York20Series A investors in United States1790Series B investors in United States563Series A healthtech investors243Series A investors in New York233

Questions

What stage does Global BioAccess Fund invest in?

Global BioAccess Fund reports entry at series a, series b.

How much does Global BioAccess Fund invest?

Global BioAccess Fund has not reported a check size.

Does Global BioAccess Fund lead rounds?

Yes. Global BioAccess Fund says it can lead.

Who are the partners at Global BioAccess Fund?

Bruce Roberts (Managing Partner), Lisa Wisniewski (Managing Director), Ted Moon (Managing Partner).

Is Global BioAccess Fund active right now?

No recent activity since September 2026.

Work at Global BioAccess Fund? Claim or correct this profile.